NCT01441128 2019-12-17
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
National Institutes of Health Clinical Center (CC)
University of Arkansas
Epimmune
Pharmacyclics LLC.